Reversed-phase liquid chromatographic determination of idarubicin and its 13-hydroxy metabolite in human plasma

This publication has 14 references indexed in Scilit:

• A phase II study of idarubicin (4-demethoxydaunorubicin) in advanced myeloma
  European Journal of Cancer and Clinical Oncology, 1988
• Effect of daunorubicin, carminomycin, idarubicin and 4-demethoxydaunorubicinol against human normal myeloid stem cells and human malignant cells In vitro
  European Journal of Cancer and Clinical Oncology, 1987
• Method for the determination of 4-Demethoxydaunorubicin, its quinone and hydroquinone metabolites in human plasma and urine by high-performance liquid chromatography
  Cancer Chemotherapy and Pharmacology, 1987
• Idarubicin (4-demethoxydaunorubicin)
  Investigational New Drugs, 1986
• Contemporary Detection Of 4-Demeth-Oxydaunorubicin And Its Metabolites 13-Dihydro-4-Demethoxydaunorubicin And4-Demethoxydaunorubicinone By Reverse Phase High-Performance Liquid Chromatography
  Journal of Liquid Chromatography, 1985
• 4-Demethoxydaunorubicin (Idarubicin) in refractory or relapsed acute leukemias. A pilot study
  Cancer, 1985
• Liquid chromatography in anticancer drug research with special reference to anthraquinone glycosides
  Journal of Pharmaceutical and Biomedical Analysis, 1984
• High-performance liquid chromatographic method for pharmacokinetic studies on the new anthracycline 4-demethoxydaunorubicin and its 13-dihydro derivative
  Journal of Chromatography B: Biomedical Sciences and Applications, 1983
• Liquid chromatogrphic determination of daunorubicin and daunorubicinol in plasma from leukemic patients
  Journal of Chromatography A, 1978
• Extraction of Daunorubicin and Doxorubicin and Their Hydroxyl Metabolites: Self-Association in Aqueous Solution
  Journal of Pharmaceutical Sciences, 1978